Pharmaceutical

Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio

Chief Executive Officer (CEO) Christian Kanstrup steps down Chief Scientific Officer Birgitte Rønø appointed interim CEO and search for new CEO…

6 months ago

PetMed Express, Inc. Provides Update on Status of Fourth Quarter and FY 2025 Results and Form 10-K Filing

DELRAY BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of…

6 months ago

Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance

Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and FDA-Cleared Oral…

6 months ago

Outlook Therapeutics Appoints Biopharmaceutical Industry and Commercial Leader Bob Jahr as Chief Executive Officer

Well-established executive with over 20 years of experience building and leading commercial teams across diverse therapeutic markets and geographies Career…

6 months ago

T-knife Therapeutics Appoints Christoph Broja to its Board of Directors

SAN FRANCISCO and BERLIN, July 01, 2025 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor…

6 months ago

Soleno Therapeutics Announces Two Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ENDO 2025

REDWOOD CITY, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel…

6 months ago

Cosmo Unveils Bold 2030 Vision and Strategy; Launches AI-Driven Growth Phase at Investor Day 2025

Ad hoc announcement pursuant to Art. 53 LR Company sets ambitious vision for €480 million in recurring revenues and a…

6 months ago

CustomerInsights.AI (CIAI) Launches ciATHENA: A Conversational, Agentic AI Platform Redefining Pharma Commercial Analytics

PHOENIX, June 30, 2025 /PRNewswire/ -- Last week CIAI announced the launch of ciATHENA, a next generation Agentic AI platform…

6 months ago

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2025 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, July 1 at 11:30 AM EDTNorthvale, New Jersey--(Newsfile Corp. - June 30, 2025) - Elite…

6 months ago

PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer

Vancouver, British Columbia--(Newsfile Corp. - June 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"),…

6 months ago